• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性类天疱疮患者死亡率的预后因素:一项荟萃分析。

Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.

作者信息

Liu Yi-Di, Wang Yan-Hong, Ye Yi-Cong, Zhao Wen-Ling, Li Li

机构信息

Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China.

Department of Epidemiology and Bio-statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

出版信息

Arch Dermatol Res. 2017 Jul;309(5):335-347. doi: 10.1007/s00403-017-1736-1. Epub 2017 Mar 19.

DOI:10.1007/s00403-017-1736-1
PMID:28317060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5486568/
Abstract

Bullous pemphigoid (BP) is a chronic debilitating autoimmune blistering disease that frequently occurs in the elderly population. Previous studies have suggested a high morbidity and mortality associated with BP. However, relatively few studies have investigated prognostic factors of BP mortality, and they showed considerably various results. This meta-analysis aimed to quantitatively assess the association between several potential prognostic factors and risk of mortality in bullous pemphigoid. A comprehensive search was performed using Pubmed, Embase, and Cochrane Library. Cohort studies that assessed prognostic factors of BP mortality were included. Random-effects model was utilized to calculate the pooled hazard ratio (HR). Publication bias was evaluated qualitatively by constructing a funnel plot and quantitatively by conducting Egger's test. 14 studies were included comprising 2499 patients. Combined HRs suggested that advanced age (HR 1.63, 95% CI 1.34-1.97), presence of circulating antibodies (HR 1.77, 95% CI 1.20-2.62), concomitant dementia (HR 2.01, 95% CI 1.22-3.33), and concomitant stroke (HR 1.86, 95% CI 1.29-2.67) have an unfavorable impact on patient survival. Gender, disease extent, mucosal involvement, and indirect immunofluorescence result were not shown to be linked to mortality by our analysis. This study indicated that BP patients with older age, circulating antibodies, dementia, and stroke are at greater risk of mortality. Clinicians should be aware of this association and utilize this information in patient education and treatment process.

摘要

大疱性类天疱疮(BP)是一种慢性致残性自身免疫性水疱病,常见于老年人群。既往研究提示BP具有较高的发病率和死亡率。然而,相对较少的研究调查了BP死亡率的预后因素,且结果差异较大。本荟萃分析旨在定量评估大疱性类天疱疮中几种潜在预后因素与死亡风险之间的关联。使用PubMed、Embase和Cochrane图书馆进行了全面检索。纳入评估BP死亡率预后因素的队列研究。采用随机效应模型计算合并风险比(HR)。通过构建漏斗图进行定性评估发表偏倚,并通过Egger检验进行定量评估。纳入14项研究,共2499例患者。合并HR提示,高龄(HR 1.63,95%CI 1.34 - 1.97)、循环抗体阳性(HR 1.77,95%CI 1.20 - 2.62)、合并痴呆(HR 2.01,95%CI 1.22 - 3.33)和合并中风(HR 1.86,95%CI 1.29 - 2.67)对患者生存有不利影响。我们的分析未显示性别、疾病范围、黏膜受累情况和间接免疫荧光结果与死亡率有关。本研究表明,年龄较大、有循环抗体、患痴呆和中风的BP患者死亡风险更高。临床医生应了解这种关联,并在患者教育和治疗过程中利用这些信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/06c459d90b12/403_2017_1736_Fig10a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/a4f5987cb7e5/403_2017_1736_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/ada01f40a397/403_2017_1736_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/3b1815b53b59/403_2017_1736_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/903bbe326527/403_2017_1736_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/3070231d8e5c/403_2017_1736_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/7b6c29575c2d/403_2017_1736_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/ae4d90fedcaa/403_2017_1736_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/fe5d5de15983/403_2017_1736_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/55b1c3144003/403_2017_1736_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/06c459d90b12/403_2017_1736_Fig10a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/a4f5987cb7e5/403_2017_1736_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/ada01f40a397/403_2017_1736_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/3b1815b53b59/403_2017_1736_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/903bbe326527/403_2017_1736_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/3070231d8e5c/403_2017_1736_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/7b6c29575c2d/403_2017_1736_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/ae4d90fedcaa/403_2017_1736_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/fe5d5de15983/403_2017_1736_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/55b1c3144003/403_2017_1736_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05d5/5486568/06c459d90b12/403_2017_1736_Fig10a_HTML.jpg

相似文献

1
Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.大疱性类天疱疮患者死亡率的预后因素:一项荟萃分析。
Arch Dermatol Res. 2017 Jul;309(5):335-347. doi: 10.1007/s00403-017-1736-1. Epub 2017 Mar 19.
2
Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.大疱性类天疱疮及其与神经系统疾病的关联:一项系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2007-2015. doi: 10.1111/jdv.13660. Epub 2016 Sep 7.
3
Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.大疱性类天疱疮病死率的预后因素:系统评价和荟萃分析。
PLoS One. 2022 Apr 15;17(4):e0264705. doi: 10.1371/journal.pone.0264705. eCollection 2022.
4
A possible association between BP230-type bullous pemphigoid and dementia: a report of two cases in elderly patients.BP230型大疱性类天疱疮与痴呆之间可能存在的关联:两例老年患者报告
Br J Dermatol. 2018 Jun;178(6):1449-1450. doi: 10.1111/bjd.16249. Epub 2018 Apr 6.
5
Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.与治疗第一年中大疱性类天疱疮复发相关的临床和免疫学因素:一项多中心前瞻性研究。
JAMA Dermatol. 2014 Jan;150(1):25-33. doi: 10.1001/jamadermatol.2013.5757.
6
Autoantibody serum levels and intensity of pruritus in bullous pemphigoid.大疱性类天疱疮患者的自身抗体血清水平与瘙痒程度
Eur J Dermatol. 2016 Aug 1;26(4):390-1. doi: 10.1684/ejd.2016.2793.
7
The association between bullous pemphigoid and neurological disorders: a systematic review.大疱性类天疱疮与神经系统疾病之间的关联:一项系统综述。
Eur J Dermatol. 2017 Oct 1;27(5):472-481. doi: 10.1684/ejd.2017.3066.
8
Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.用于诊断大疱性类天疱疮的1型和2型大疱性类天疱疮抗原组合的酶联免疫吸附测定。
Arch Dermatol. 2011 Mar;147(3):293-8. doi: 10.1001/archdermatol.2011.21.
9
Sensitivities and utility of non-invasive serological tests in the diagnosis of bullous pemphigoid.非侵入性血清学检测在大疱性类天疱疮诊断中的敏感性及实用性
Int J Dermatol. 2016 Sep;55(9):e510-1. doi: 10.1111/ijd.13283. Epub 2016 Mar 29.
10
Demographics and Autoantibody Profiles of Pemphigoid Patients with Underlying Neurologic Diseases.神经疾病相关天疱疮患者的人口统计学和自身抗体特征。
J Invest Dermatol. 2019 Sep;139(9):1860-1866.e1. doi: 10.1016/j.jid.2019.01.034. Epub 2019 Mar 12.

引用本文的文献

1
Bullous Pemphigoid Overlapping Psoriasis Vulgaris: A Rare Case Report and Literature Review.大疱性类天疱疮重叠寻常型银屑病:1例罕见病例报告及文献复习
Clin Pract. 2025 May 8;15(5):91. doi: 10.3390/clinpract15050091.
2
Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis.与大疱性类天疱疮风险相关的慢性病:一项系统评价和荟萃分析。
JAAD Int. 2024 Sep 7;17:141-152. doi: 10.1016/j.jdin.2024.08.010. eCollection 2024 Dec.
3
Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches.

本文引用的文献

1
Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease.大疱性类天疱疮BP180自身抗体水平升高与阿尔茨海默病中更严重的痴呆症相关。
J Invest Dermatol. 2017 Jan;137(1):71-76. doi: 10.1016/j.jid.2016.09.010. Epub 2016 Sep 17.
2
Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis.大疱性类天疱疮及其与神经系统疾病的关联:一项系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2007-2015. doi: 10.1111/jdv.13660. Epub 2016 Sep 7.
3
Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.
靶向大疱性类天疱疮中的2型炎症:当前及新兴治疗方法
Front Med (Lausanne). 2023 Aug 8;10:1196946. doi: 10.3389/fmed.2023.1196946. eCollection 2023.
4
Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study.大疱性类天疱疮患者发生严重感染的风险:一项基于人群的队列研究。
Acta Derm Venereol. 2023 Jun 5;103:adv5329. doi: 10.2340/actadv.v103.5329.
5
The efficacy of adding oral sodium cromoglycate to stable treatment for controlling bullous pemphigoid-related pruritus: A retrospective study.添加口服色甘酸钠至稳定治疗方案中用于控制大疱性类天疱疮相关瘙痒的疗效:一项回顾性研究。
Front Med (Lausanne). 2022 Dec 8;9:1051804. doi: 10.3389/fmed.2022.1051804. eCollection 2022.
6
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.大疱性类天疱疮初始激素联合利妥昔单抗治疗的临床疗效及安全性:一项回顾性队列研究。
Am J Clin Dermatol. 2022 Jul;23(4):571-585. doi: 10.1007/s40257-022-00688-x. Epub 2022 May 17.
7
Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.大疱性类天疱疮病死率的预后因素:系统评价和荟萃分析。
PLoS One. 2022 Apr 15;17(4):e0264705. doi: 10.1371/journal.pone.0264705. eCollection 2022.
8
Bullous pemphigoid: An immune disorder related to aging (Review).大疱性类天疱疮:一种与衰老相关的免疫紊乱(综述)
Exp Ther Med. 2022 Jan;23(1):50. doi: 10.3892/etm.2021.10972. Epub 2021 Nov 15.
9
Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid.难治性大疱性类天疱疮的新兴生物标志物和治疗策略。
Front Immunol. 2021 Aug 24;12:718073. doi: 10.3389/fimmu.2021.718073. eCollection 2021.
10
Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review.大疱性类天疱疮黏膜受累的危险因素及可能机制:综述
Front Med (Lausanne). 2021 May 20;8:680871. doi: 10.3389/fmed.2021.680871. eCollection 2021.
美国大疱性类天疱疮的住院情况、住院负担和合并症
Br J Dermatol. 2017 Jan;176(1):87-99. doi: 10.1111/bjd.14821. Epub 2016 Oct 29.
4
Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland.大疱性类天疱疮的死亡风险:芬兰的一项回顾性数据库研究
Acta Derm Venereol. 2016 Aug 23;96(6):758-61. doi: 10.2340/00015555-2347.
5
Mortality of patients with bullous pemphigoid in Korea.韩国大疱性类天疱疮患者的死亡率。
J Am Acad Dermatol. 2014 Oct;71(4):676-83. doi: 10.1016/j.jaad.2014.05.006. Epub 2014 Jun 12.
6
Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.明尼苏达州奥姆斯特德县 1960 年至 2009 年大疱性类天疱疮的发病率和死亡率。
J Am Acad Dermatol. 2014 Jul;71(1):92-9. doi: 10.1016/j.jaad.2014.02.030. Epub 2014 Apr 3.
7
Diagnosis and classification of pemphigus and bullous pemphigoid.天疱疮和大疱性类天疱疮的诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):477-81. doi: 10.1016/j.autrev.2014.01.011. Epub 2014 Jan 11.
8
Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities).缩小质量差距:重新审视科学现状(第3卷:解决健康差异的质量改进干预措施)
Evid Rep Technol Assess (Full Rep). 2012 Aug(208.3):1-475.
9
Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre.新加坡大疱性类天疱疮患者的死亡率:在国家皮肤中心就诊的 359 例患者的死亡风险因素和死因。
Br J Dermatol. 2014 Jun;170(6):1319-26. doi: 10.1111/bjd.12806. Epub 2014 Apr 29.
10
Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.与治疗第一年中大疱性类天疱疮复发相关的临床和免疫学因素:一项多中心前瞻性研究。
JAMA Dermatol. 2014 Jan;150(1):25-33. doi: 10.1001/jamadermatol.2013.5757.